Genmab A/S (GNMSF) Intangibles (2018 - 2026)
Genmab A's (GNMSF) quarterly Intangibles came in at $8.9 billion in Q1 2026, up 409.57% YoY from $1.8 billion in Q1 2025, and down 1.92% on a QoQ basis from $9.1 billion in Q4 2025.
Genmab A/S (GNMSF) Intangibles (2018 - 2026) Analysis & Trends
Genmab A (GNMSF) has 7 years of Intangibles data on file, last reported at $8.9 billion in Q1 2026.
- Quarterly Intangibles rose 409.57% year-over-year to $8.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 billion (up 409.57% YoY) and the FY2025 annual result came in at $9.1 billion, up 427.95% from the prior year.
- Intangibles declined to $8.9 billion in Q1 2026, from $9.1 billion in the prior quarter.
- In the past five years, Intangibles ranged from a high of $9.1 billion in Q4 2025 to a low of $15.0 million in Q4 2023.
- A 4-year average of $3.6 billion and a median of $1.8 billion in 2025 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles soared 11420.0% — and 2026, when it jumped 409.57%.
- Tracing GNMSF's Intangibles over 4 years: stood at $15.0 million in 2023, then soared by 11420.0% to $1.7 billion in 2024, then surged by 427.95% to $9.1 billion in 2025, then declined by 1.92% to $8.9 billion in 2026.
- The last three Intangibles figures came in at $8.9 billion (Q1 2026), $9.1 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.87 Bn |
| Mar 31, 2026 | 8.95 Bn |
| Dec 31, 2025 | 9.12 Bn |
| Sep 30, 2025 | 1.75 Bn |
| Jun 30, 2025 | 1.75 Bn |
| Mar 31, 2025 | 1.76 Bn |
| Dec 31, 2024 | 1.73 Bn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2020 | 385.00 |
| Dec 31, 2019 | 470.00 |
| Sep 30, 2019 | 419.63 Mn |
| Dec 31, 2018 | 470.36 Mn |